Analystreport

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target lowered by analysts at HC Wainwright from $50.00 to $33.00.

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com